TCL Archive Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says October 29, 1999
TCL Archive BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal June 21, 2002
TCL Archive ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer October 9, 2009
TCL Archive Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program March 11, 1994